(Q56) Indeterminate sex and pseudohermaphroditism

More details coming soon

Icon
7 198 in individuals diagnosis indeterminate sex and pseudohermaphroditism confirmed

Diagnosis indeterminate sex and pseudohermaphroditism is diagnosed Women are 18.12% more likely than Men

2 947

Men receive the diagnosis indeterminate sex and pseudohermaphroditism

0 (less than 0.1%)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 251

Women receive the diagnosis indeterminate sex and pseudohermaphroditism

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease indeterminate sex and pseudohermaphroditism - Men aged 0 and Women aged 15-19

Icon
In Men diagnosis is most often set at age 0-5, 10-24, 35-39, 60-64
Icon
Less common in men the disease occurs at Age 5-9, 25-34, 40-59, 65-95+Less common in women the disease occurs at Age 25-29, 35-44, 50-95+
Icon
In Women diagnosis is most often set at age 0-24, 30-34, 45-49

Disease Features indeterminate sex and pseudohermaphroditism

Icon
Non-contagious
Icon
Absence or low individual and public risk
Icon

Indeterminate sex and pseudohermaphroditism - what does this mean

Indeterminate sex and pseudohermaphroditism occur when the genetic sex of an individual is different from their gonadal and/or phenotypic sex. this can be due to chromosomal abnormalities, hormonal imbalances, or other environmental factors.

What happens during the disease - indeterminate sex and pseudohermaphroditism

More details coming soon

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical Examination
  • Genetic Testing
  • Hormonal Assays
  • Ultrasound Imaging
  • Chromosomal Analysis
  • Karyotyping
  • MRI or CT Scan

Treatment and Medical Assistance

Main Goal: Treating indeterminate sex and pseudohermaphroditism
  • Evaluate the patient's hormone levels
  • Perform a physical examination
  • Order genetic tests to determine the patient's sex
  • Perform imaging tests such as ultrasound or MRI
  • Prescribe hormone replacement therapy (HRT) to correct hormone levels
  • Refer the patient to a specialist if necessary
  • Provide counseling for the patient and their family
  • Perform surgery to correct any physical abnormalities
Icon
8 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Indeterminate sex and pseudohermaphroditism - Prevention

Indeterminate sex and pseudohermaphroditism can be prevented by ensuring that pregnant women get regular prenatal care, including ultrasounds to assess fetal gender. genetic counseling is also recommended for couples with a family history of this condition. additionally, avoiding exposure to environmental toxins, such as certain medications and chemicals, may help reduce the risk of this condition.

Specified forms of the disease

(M60.0) Infective myositis
(M60.1) Interstitial myositis
(M60.2) Foreign body granuloma of soft tissue, not elsewhere classified
(M60.8) Other myositis
(M60.9) Myositis, unspecified